Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding studyXavier Paoletti, Benoît Baron, Patrick Schöffski, et al.BMJ Open|October 20, 2019
Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysisChanghao Chen, Hao Huang, Yue Zhao, et al.Statistics in Medicine|July 22, 2014
Variable selection in subdistribution hazard frailty models with competing risks dataIl Do Ha, Minjung Lee, Seungyoung Oh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer GroupJulie Francart, Catherine Legrand, Richard Sylvester, et al.European Urology|April 5, 2011
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 updateMarko Babjuk, Willem Oosterlinck, Richard Sylvester, et al.The Journal of Urology|February 10, 2004
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysisRobert C Flanigan, G Mickisch, Richard Sylvester, et al.European Urology|January 29, 2011
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 updateMorgan Rouprêt, Richard Zigeuner, Juan Palou, et al.Statistics in Medicine|December 17, 2002
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selectionKristel Van Steen, Desmond Curran, Jocelyn Kramer, et al.European Urology|December 9, 2009
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancerPaolo Gontero, Andreas Bohle, Per-Uno Malmstrom, et al.European Urology|December 16, 2010
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al.Pageof 9